BioPharm International
September 03, 2014
Features
27
9
This article is the third and final in a series designed to offer leaders and managers at all levels in the industry a road map to excellence in human performance and human error prevention.
September 01, 2014
Global News
27
9
Chinese healthcare reforms may be a double-edged sword for foreign companies.
September 01, 2014
Regulatory Beat
27
9
As the pharmacovigilance infrastructure becomes more entrenched in Europe, drug manufacturers are beginning to feel the burden of its high cost.
September 01, 2014
Perspectives on Outsourcing
27
9
Annual study shows geographic proximity not a factor in CMO selection.
September 01, 2014
Regulatory Beat
27
9
FDA demands accurate manufacturing and test information to ensure product quality.
September 01, 2014
Features
27
9
Careful selection of downstream processing conditions is a must.
September 01, 2014
Features
27
9
Vial adapters can reduce variation of volume withdrawn from injectable drug vials.
September 01, 2014
Compliance Notes
27
9
A well-constructed quality agreement can be an important tool to enable effective collaboration between owner and CMO.
September 01, 2014
Guest Editorial
27
9
Industry associations play a strong role in helping the pharmaceutical industry meet challenges.
September 01, 2014
Troubleshooting
27
9
Developing and maintaining a current master plan for cleaning in multi-product facilities are crucial.
September 01, 2014
Features
27
9
Program review can help quality risk management live up to the promise of ICH Q9.
September 01, 2014
Cover Story
27
9
Experts discuss the future of modular manufacturing and the challenges that biopharma manufacturers face in facility design
September 01, 2014
Analytical Best Practices
27
9
Design space generation is encouraged in new product development.
September 01, 2014
Issue PDF
27
9
Click the title above to open the BioPharm International September 2014 issue in an interactive PDF format.